We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+0.72%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$304B
AUM Growth
-$14.5B
Cap. Flow
-$11.3B
Cap. Flow %
-3.72%
Top 10 Hldgs %
15.32%
Holding
7,717
New
593
Increased
2,914
Reduced
3,244
Closed
656

Sector Composition

Rank Sector Weight
1 Financials 8.59%
2 Technology 8.45%
3 Healthcare 7.6%
4 Consumer Discretionary 6.86%
5 Energy 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XEC
4251
CALL
DELISTED
CIMAREX ENERGY CO
XEC
$768K ﹤0.01%
7,900
-7,100
-47% -$624K
PX
4252
CALL
DELISTED
Praxair Inc
PX
$767K ﹤0.01%
6,700
-7,900
-54% -$825K
ESPR
4253
CALL
DELISTED
Esperion Therapeutics
ESPR
$766K ﹤0.01%
45,300
-8,000
-15% -$129K
FXU icon
4254
First Trust Utilities AlphaDEX Fund
FXU
$821M
$766K ﹤0.01%
29,495
-296,728
-91% -$7.01M
ZIXI
4255
DELISTED
Zix Corporation
ZIXI
$766K ﹤0.01%
194,905
+114,610
+143% +$479K
ARIA
4256
CALL
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$765K ﹤0.01%
119,700
+48,400
+68% +$271K
HTH icon
4257
Hilltop Holdings
HTH
$2.28B
$764K ﹤0.01%
40,457
-18,046
-31% -$305K
PTXP
4258
DELISTED
PennTex Midstream Partners, LP Common Units Reresenting Limited Partnership Interests
PTXP
$761K ﹤0.01%
75,000
-67
-0.1% -$707
UXI icon
4259
ProShares Ultra Industrials
UXI
$33.2M
$759K ﹤0.01%
79,476
-39,540
-33% -$325K
SWBI icon
4260
CALL
Smith & Wesson
SWBI
$658M
$756K ﹤0.01%
36,948
-13,010
-26% -$242K
IMGN
4261
DELISTED
Immunogen Inc
IMGN
$756K ﹤0.01%
88,667
+16,684
+23% +$141K
WNR
4262
PUT
DELISTED
Western Refining Inc
WNR
$756K ﹤0.01%
26,000
+4,300
+20% +$130K
IBRX icon
4263
ImmunityBio
IBRX
$7.59B
$755K ﹤0.01%
91,809
-136,786
-60% -$1.29M
IRDM icon
4264
Iridium Communications
IRDM
$5.13B
$755K ﹤0.01%
95,961
+75,564
+370% +$543K
INSM icon
4265
CALL
Insmed
INSM
$21.5B
$754K ﹤0.01%
59,500
-500
-0.8% -$6.57K
INSM icon
4266
PUT
Insmed
INSM
$21.5B
$754K ﹤0.01%
59,500
-500
-0.8% -$6.57K
MPWR icon
4267
Monolithic Power Systems
MPWR
$66.1B
$752K ﹤0.01%
11,806
-16,476
-58% -$982K
RDUS
4268
CALL
DELISTED
Radius Health, Inc.
RDUS
$751K ﹤0.01%
23,900
-76,300
-76% -$2.64M
LVNTA
4269
CALL
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$751K ﹤0.01%
+19,200
New +$729K
EXP icon
4270
PUT
Eagle Materials
EXP
$6.7B
$750K ﹤0.01%
10,700
+4,600
+75% +$268K
MOV icon
4271
Movado Group
MOV
$867M
$750K ﹤0.01%
27,217
-22,127
-45% -$592K
DGII icon
4272
Digi International
DGII
$2.74B
$748K ﹤0.01%
79,358
-61,665
-44% -$562K
PSP icon
4273
Invesco Global Listed Private Equity ETF
PSP
$245M
$748K ﹤0.01%
14,509
+6,956
+92% +$337K
AMRN
4274
CALL
Amarin Corp
AMRN
$302M
$747K ﹤0.01%
24,400
-530
-2% -$15.7K
MGC icon
4275
Vanguard Morningstar Mega Cap ETF
MGC
$10.3B
$747K ﹤0.01%
10,650

Similar funds

Goldman Sachs's Q1 2016 Portfolio in Review

As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.

  • Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
  • Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
  • Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
  • Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
  • Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
  • Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
  • Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.

Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.